Pharmaceutical Industry News

Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.

Medicines Shortages in Europe: PGEU Report 2024 Points to Critical Scenario

The PGEU has reported widespread medicine shortages across all 28 countries in 2024, with pharmacists spending more time managing the issue....
INFARMED’s New Medicine Availability Regulation in Portugal

New Regulation on Medicine Availability in Portugal

Resolution No. 233/2025 updates medicine availability regulations, strengthening supply chains and export controls to prevent shortages in Portugal....
RDC No. 947: Anvisa Shifts to 100% Digital Protocol Processes

RDC No. 947: Anvisa Shifts to 100% Digital Protocol Processes

With Resolution RDC No. 947, Anvisa aims to reduce costs associated with storing and digitizing physical documents, while ensuring the authenticity and...

Sammed available for 2024 H2 Marketing Report Submission – Ensure Compliance for 2025

The Medicines Market Monitoring System (Sammed) is open for 2024 H2 marketing report submissions. Meet the March 14, 2025 deadline to qualify...
Anvisa atualiza Lista de Medicamentos de Referência

Anvisa updates the Reference Medicines List.

The National Health Surveillance Agency (ANVISA) has updated the Reference Drug List, which classifies medications into groups based on their composition....

European Shortages Monitoring Platform: A New Era in Medicine Management

The European Shortage Monitoring Platform (ESMP), launched on January 29, 2025, enhances the monitoring and management of medicine shortages across the EU....

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.